Concord Wealth Partners Guardant Health, Inc. Transaction History
Concord Wealth Partners
- $673 Million
- Q2 2025
A detailed history of Concord Wealth Partners transactions in Guardant Health, Inc. stock. As of the latest transaction made, Concord Wealth Partners holds 8 shares of GH stock, worth $403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8Holding current value
$403% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
401Shares Held
123MCall Options Held
1.43MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.1MShares$609 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$566 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$274 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$259 Million0.04% of portfolio
-
Baillie Gifford & CO4.81MShares$242 Million0.2% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.15B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...